EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study

Raúl Velamazán iD, Pablo López-Guillén iD, Samuel J Martínez-Domínguez iD, Daniel Abad Baroja, Daniel Oyón iD, Anna Arnau, Lara M Ruiz-Belmonte, Javier Tejedor-Tejada iD, Raul Zapater, Noelia Martín-Vicente, Pedro José Fernández-Esparcia, Ana Belén Julián Gomara und 22 weitere

United European Gastroenterology Journal · 2024-04 · 12 (3) · 286-298

DOI: 10.1002/ueg2.12544 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 20.02.2024. Verfasst von Raúl Velamazán und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. Hauptthemen laut MEDLINE: Pancreatitis, Choledocholithiasis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AEG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Delayed cholecystectomy in patients with symptomatic gallstone disease is associated with recurrence. Limited data on the recurrence patterns and the factors that determine them are available.

Objective

We aimed to determine the pattern of relapse in each symptomatic gallstone disease (acute pancreatitis, cholecystitis, cholangitis, symptomatic choledocholithiasis, and biliary colic) and determine the associated factors.

Methods

RELAPSTONE was an international multicenter retrospective cohort study. Patients ( n = 3016) from 18 tertiary centers who suffered a first episode of symptomatic gallstone disease from 2018 to 2020 and had not undergone cholecystectomy during admission were included. The main outcome was relapse‐free survival. Kaplan–Meier curves were used in the bivariate analysis. Multivariable Cox regression models were used to identify prognostic factors associated with relapses.

Results

Mean age was 76.6 [IQR: 59.7–84.1], and 51% were male. The median follow‐up was 5.3 months [IQR 2.1–12.4]. Relapse‐free survival was 0.79 (95% CI: 0.77–0.80) at 3 months, 0.71 (95% CI: 0.69–0.73) at 6 months, and 0.63 (95% CI: 0.61–0.65) at 12 months. In multivariable analysis, older age (HR = 0.57; 95% CI: 0.49–0.66), sphincterotomy (HR = 0.58, 95% CI: 0.49–0.68) and higher leukocyte count (HR = 0.79; 95% CI: 0.70–0.90) were independently associated with lower risk of relapse, whereas higher levels of alanine aminotransferase (HR = 1.22; 95% CI: 1.02–1.46) and multiple cholelithiasis (HR = 1.19, 95% CI: 1.05–1.34) were associated with higher relapse rates.

Conclusion

The relapse rate is high and different in each symptomatic gallstone disease. Our independent predictors could be useful for prioritizing patients on the waiting list for cholecystectomies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisCholedocholithiasisHumansMaleAgedFemaleRetrospective StudiesAcute DiseaseRisk FactorsRecurrence

Stichwörter der Autor:innen

biliary colicbiliary paincholangitischolecystectomycholecystitischolelithiasisgallstonespancreatitisrecurrencesrelapse

Autor:innen und Institutionen

  • Department of Gastroenterology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
  • Department of Gastroenterology, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Spain.
  • IIS (Instituto de Investigacion Sanitaria) Aragón, Zaragoza, Spain.
  • Department of Gastroenterology, Hospital General Universitario Dr.Balmis, Alicante, Spain.
  • ISABIAL (Instituto de Investigación Sanitaria y Biomédica de Alicante), Alicante, Spain.
  • Department of Gastroenterology, Hospital Universitario Miguel Servet, Zaragoza, Spain.

ORCID-Profile: Raúl Velamazán, Pablo López-Guillén, Samuel J Martínez-Domínguez, Daniel Oyón, Javier Tejedor-Tejada, María Vaamonde Lorenzo, Enrique de-Madaria

Förderung

  • AEG

Zitieren

APA

Velamazán, R., López-Guillén, P., Martínez-Domínguez, S. J., Abad Baroja, D., Oyón, D., Arnau, A., Ruiz-Belmonte, L. M., Tejedor-Tejada, J., Zapater, R., Martín-Vicente, N., Fernández-Esparcia, P. J., Julián Gomara, A. B., Sastre Lozano, V., Manzanares García, J. J., Chivato Martín-Falquina, I., Andrés Pascual, L., Torres Monclus, N., Zaragoza Velasco, N., Rojo, E., …, & de-Madaria, E. (2024). Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study. United European Gastroenterology Journal, 12(3), 286-298. https://doi.org/10.1002/ueg2.12544

Vancouver

Velamazán R, López-Guillén P, Martínez-Domínguez SJ, Abad Baroja D, Oyón D, Arnau A, et al. Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study. United European Gastroenterology Journal. 2024;12(3):286-298. doi:10.1002/ueg2.12544

BibTeX
@article{Velamazn2024,
  author = {Velamazán, Raúl and López-Guillén, Pablo and Martínez-Domínguez, Samuel J and Abad Baroja, Daniel and Oyón, Daniel and Arnau, Anna and Ruiz-Belmonte, Lara M and Tejedor-Tejada, Javier and Zapater, Raul and Martín-Vicente, Noelia and Fernández-Esparcia, Pedro José and Julián Gomara, Ana Belén and Sastre Lozano, Violeta and Manzanares García, Juan José and Chivato Martín-Falquina, Irene and Andrés Pascual, Laura and Torres Monclus, Nuria and Zaragoza Velasco, Natividad and Rojo, Eukene and Lapeña-Muñoz, Berta and Flores, Virginia and Díaz Gómez, Arantxa and Cañamares-Orbís, Pablo and Vinzo Abizanda, Isabel and Marcos Carrasco, Natalia and Pardo Grau, Laura and García-Rayado, Guillermo and Millastre Bocos, Judith and Garcia Garcia de Paredes, Ana and Vaamonde Lorenzo, María and Izagirre Arostegi, Arantzazu and Lozada-Hernández, Edgard Efrén and Velarde-Ruiz Velasco, José Antonio and de-Madaria, Enrique},
  title = {Symptomatic gallstone disease: Recurrence patterns and risk factors for relapse after first admission, the RELAPSTONE study},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  volume = {12},
  number = {3},
  pages = {286--298},
  doi = {10.1002/ueg2.12544}
}
Kostenlos starten →